TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scius Pharma Support AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
587
|
818
|
936 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-269
|
-295
|
59 |
| EBITDA |
-273
|
-298
|
59 |
| Total assets |
781
|
1,058
|
1,501 |
| Current assets |
781
|
1,058
|
1,501 |
| Current liabilities |
96
|
121
|
86 |
| Equity capital |
685
|
937
|
1,415 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
87.7%
|
88.6%
|
94.3% |
| Turnover per employee |
587
|
818
|
936 |
| Profit as a percentage of turnover |
-45.8%
|
-36.1%
|
6.3% |
| Return on assets (ROA) |
-34.4%
|
-27.9%
|
3.9% |
| Current ratio |
813.5%
|
874.4%
|
1745.3% |
| Return on equity (ROE) |
-39.3%
|
-31.5%
|
4.2% |
| Change turnover |
-245
|
-185
|
-393 |
| Change turnover % |
-29%
|
-18%
|
-30% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.